{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:41:30Z","timestamp":1787316090366,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a knowledge gap regarding the treatment patterns of patients with major depressive disorder (MDD) who experience suicidal ideation or a suicide attempt (SI\/SA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with SI\/SA were identified from a large US-based claims database covering 84 million lives, during 1\/1\/2014\u20133\/31\/2020. Patients with MDD were indexed at their first diagnosis for SI\/SA and followed up to 365\u2009days. Treatment patterns were captured at the class level and included procedures of electroconvulsive therapy and transcranial magnetic stimulation, and pharmacotherapy including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, other antidepressants, anxiolytics, hypnotics\/sedatives, antipsychotics, psychostimulants, and lithium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 42,204 MDD\u2009+\u2009SI\/SA patients identified. In the year prior to the index event &gt;\u200940% of individuals received an SSRI and more than one-third received an anxiolytic. Within 1\u2009year following, 84.4% received \u22651 of the treatments of interest. Of those, 70.2% went on to a subsequent class-based regimen, 46.3% received a third, and 28.1% received \u22654. More than three-quarters of patients received multiple treatment classes simultaneously. SSRIs were the most common treatments during follow-up (61.9%), followed by other antidepressants (51.3%), anxiolytics (50.8%) and anticonvulsants (43.6%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There was a large amount of variability and polypharmacy in the treatments received by MDD patients with SI\/SA, and is much more complex than what has been previously observed in the general MDD population. Within one-year, many patients received four or more unique class-based regimens and most patients received treatments from multiple classes simultaneously, indicating the high unmet medical need and therapy refractoriness of this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-021-03616-1","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T04:02:50Z","timestamp":1638763370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment patterns of patients diagnosed with major depressive disorder and suicidal ideation or attempt: a U.S. population-based study utilizing real-world data"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-3925","authenticated-orcid":false,"given":"David M.","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Soledad","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"3616_CR1","volume-title":"Major depression","author":"National Institute of Mental Health","year":"2019","unstructured":"National Institute of Mental Health. Major depression. 2019. [cited 2020 Sep 2]. Available from: https:\/\/www.nimh.nih.gov\/health\/statistics\/major-depression.shtml."},{"issue":"Suppl 2","key":"3616_CR2","first-page":"56","volume":"60","author":"J Angst","year":"1999","unstructured":"Angst J, Angst F, Stassen HH. Suicide risk in patients with major depressive disorder. J Clin Psychiatry. 1999;60(Suppl 2):56\u201357, 113-116.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"3616_CR3","first-page":"1500","volume":"59","author":"MF Gliatto","year":"1999","unstructured":"Gliatto MF, Rai AK. Evaluation and treatment of patients with suicidal ideation. Am Fam Physician. 1999;59(6):1500\u20136.","journal-title":"Am Fam Physician"},{"issue":"3","key":"3616_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2105\/AJPH.2013.301600","volume":"104","author":"B Han","year":"2014","unstructured":"Han B, McKeon R, Gfroerer J. Suicidal ideation among community-dwelling adults in the United States. Am J Public Health. 2014;104(3):488\u201397.","journal-title":"Am J Public Health"},{"key":"3616_CR5","volume-title":"Suicidal thoughts and behavior among adults: results from the 2015 National Survey on Drug Use and Health. NSDUH data review","author":"K Piscopo","year":"2016","unstructured":"Piscopo K, Lipari RN, Cooney J, Glasheen C. Suicidal thoughts and behavior among adults: results from the 2015 National Survey on Drug Use and Health. NSDUH data review: Substance Abuse and Mental Health Services Administration; 2016. [cited 2020 Sep 14]. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DR-FFR3-2015\/NSDUH-DR-FFR3-2015.htm"},{"issue":"13","key":"3616_CR6","first-page":"1","volume":"60","author":"AE Crosby","year":"2011","unstructured":"Crosby AE, Han B, Ortega LAG, Parks SE, Gfroerer J. Suicidal thoughts and behaviors among adults aged \u226518 years--United States, 2008-2009. Morb Mortal Wkly report Surveill Summ (Washington, DC 2002). 2011;60(13):1\u201322.","journal-title":"Morb Mortal Wkly report Surveill Summ (Washington, DC 2002)"},{"issue":"20","key":"3616_CR7","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1001\/jama.293.20.2487","volume":"293","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA. 2005;293(20):2487\u201395 Available from: https:\/\/doi.org\/10.1001\/jama.293.20.2487.","journal-title":"JAMA"},{"issue":"2","key":"3616_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1176\/appi.ps.201100159","volume":"63","author":"BK Ahmedani","year":"2012","unstructured":"Ahmedani BK, Perron B, Ilgen M, Abdon A, Vaughn M, Epperson M. Suicide thoughts and attempts and psychiatric treatment utilization: informing prevention strategies. Psychiatr Serv. 2012;63(2):186\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22302340.","journal-title":"Psychiatr Serv"},{"key":"3616_CR9","unstructured":"Centers for Disease Control and Prevention. Web-based injury statistics query and reporting system (WISQARS). Leading causes of death reports, 1981\u20132018. Atlanta. U.S department of Health and Human Services. [cited 2020 Sep 14]. Available from: https:\/\/www.cdc.gov\/injury\/wisqars\/fatal.html."},{"key":"3616_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/NDT.S229530","volume":"17","author":"C Benson","year":"2021","unstructured":"Benson C, Singer D, Carpinella CM, Shawi M, Alphs L. The health-related quality of life, work productivity, healthcare resource utilization, and economic burden associated with levels of suicidal ideation among patients self-reporting moderately severe or severe major depressive disorder in a national survey. Neuropsychiatr Dis Treat. 2021;17:111\u201323 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33500620.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"10","key":"3616_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5694\/j.1326-5377.2001.tb143717.x","volume":"175","author":"RD Goldney","year":"2001","unstructured":"Goldney RD, Fisher LJ, Wilson DH, Cheok F. Suicidal ideation and health-related quality of life in the community. Med J Aust. 2001;175(10):546\u20139 Available from: https:\/\/doi.org\/10.5694\/j.1326-5377.2001.tb143717.x.","journal-title":"Med J Aust"},{"issue":"3","key":"3616_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/JGP.0b013e31820eea0c","volume":"20","author":"K Szanto","year":"2012","unstructured":"Szanto K, Dombrovski AY, Sahakian BJ, Mulsant BH, Houck PR, Reynolds CF, et al. Social emotion recognition, social functioning, and attempted suicide in late-life depression. Am J Geriatr Psychiatry. 2012;20(3):257\u201365 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1064748112600967.","journal-title":"Am J Geriatr Psychiatry"},{"key":"3616_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12991-019-0232-8","volume":"18","author":"M Pompili","year":"2019","unstructured":"Pompili M. Critical appraisal of major depression with suicidal ideation. Ann General Psychiatry. 2019;18:7 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31164909.","journal-title":"Ann General Psychiatry"},{"key":"3616_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fpsyt.2020.00325","volume":"11","author":"M Pompili","year":"2020","unstructured":"Pompili M. Intranasal esketamine and current suicidal ideation with intent in major depression disorder: beat the clock, save a life, start a strategy. Front Psychiatry. 2020;11:325 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32425826.","journal-title":"Front Psychiatry"},{"key":"3616_CR15","volume-title":"The neurobiological basis of suicide","author":"J Mann","year":"2012","unstructured":"Mann J, Currier D. Medication in suicide prevention insights from neurobiology of suicidal behavior. In: Dwivedi Y, editor. The neurobiological basis of suicide. Boca Raton: CRC Press\/Taylor & Francis; 2012. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK107195\/."},{"issue":"4","key":"3616_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4088\/PCC.v05n0405","volume":"5","author":"CG Carrigan","year":"2003","unstructured":"Carrigan CG, Lynch DJ. Managing suicide attempts: guidelines for the primary care physician. Prim Care Companion J Clin Psychiatry. 2003;5(4):169\u201374.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"3616_CR17","unstructured":"Pompili M, Goldblat MJ. Psychopharmacological treatment to reduce suicide risk. Psychiatr Times. 2012; [cited 2020 Sep 14]. Available from: https:\/\/www.psychiatrictimes.com\/view\/psychopharmacological-treatment-reduce-suicide-risk."},{"issue":"3","key":"3616_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0193-953X(05)70333-6","volume":"20","author":"KM Malone","year":"1997","unstructured":"Malone KM. Pharmacotherapy of affectively ill suicidal patients. Psychiatr Clin North Am. 1997;20(3):613\u201324.","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"3616_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/bdi.12543","volume":"19","author":"KA Smith","year":"2017","unstructured":"Smith KA, Cipriani A. Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 2017;19(7):575\u201386 Available from: https:\/\/doi.org\/10.1111\/bdi.12543.","journal-title":"Bipolar Disord"},{"issue":"6","key":"3616_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.eurpsy.2013.08.005","volume":"29","author":"M Vuorilehto","year":"2014","unstructured":"Vuorilehto M, Valtonen HM, Melartin T, Sokero P, Suominen K, Isomets\u00e4 ET. Method of assessment determines prevalence of suicidal ideation among patients with depression. Eur Psychiatry. 2014;29(6):338\u201344 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0924933813001065.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"3616_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12888-019-2418-7","volume":"20","author":"DM Kern","year":"2020","unstructured":"Kern DM, Cepeda MS, Defalco F, Etropolski M. Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019. BMC Psychiatry. 2020;20(1):4 Available from: https:\/\/doi.org\/10.1186\/s12888-019-2418-7.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"3616_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/ije\/dyz038","volume":"48","author":"RS Swain","year":"2019","unstructured":"Swain RS, Taylor LG, Braver ER, Liu W, Pinheiro SP, Mosholder AD. A systematic review of validated suicide outcome classification in observational studies. Int J Epidemiol. 2019;48(5):1636\u201349 Available from: https:\/\/doi.org\/10.1093\/ije\/dyz038.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"3616_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1176\/appi.ajp.2016.16010077","volume":"174","author":"Y Barak-Corren","year":"2016","unstructured":"Barak-Corren Y, Castro VM, Javitt S, Hoffnagle AG, Dai Y, Perlis RH, et al. Predicting suicidal behavior from longitudinal electronic health records. Am J Psychiatry. 2016;174(2):154\u201362 Available from: https:\/\/doi.org\/10.1176\/appi.ajp.2016.16010077.","journal-title":"Am J Psychiatry"},{"key":"3616_CR24","unstructured":"Hedegaard H, Schoenbaum M, Claassen C, Crosby A, Holland K, Proescholdbell S. Issues in developing a surveillance case definition for nonfatal suicide attempt and intentional self-harm using international classification of diseases, tenth revision, clinical modification (ICD-10-CM) coded data. Natl Health Stat Report. 2018;(108):1\u201319."},{"key":"3616_CR25","doi-asserted-by":"publisher","first-page":"112810","DOI":"10.1016\/j.psychres.2020.112810","volume":"285","author":"MS Cepeda","year":"2020","unstructured":"Cepeda MS, Schuemie M, Kern DM, Reps J, Canuso C. Frequency of rehospitalization after hospitalization for suicidal ideation or suicidal behavior in patients with depression. Psychiatry Res. 2020;285:112810 Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165178120301530.","journal-title":"Psychiatry Res"},{"issue":"4","key":"3616_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1062860606288243","volume":"21","author":"LI Solberg","year":"2006","unstructured":"Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O\u2019Connor PJ. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual. 2006;21(4):238\u201345.","journal-title":"Am J Med Qual"},{"key":"3616_CR27","volume-title":"SNOMED CT 5-step briefing","author":"SNOMED CT","year":"2019","unstructured":"SNOMED CT. SNOMED CT 5-step briefing. 2019. Available from: http:\/\/www.snomed.org\/snomed-ct\/five-step-briefing."},{"issue":"12","key":"3616_CR28","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/jamia\/ocy124","volume":"25","author":"G Hripcsak","year":"2018","unstructured":"Hripcsak G, Levine ME, Shang N, Ryan PB. Effect of vocabulary mapping for conditions on phenotype cohorts. J Am Med Inform Assoc. 2018;25(12):1618\u201325.","journal-title":"J Am Med Inform Assoc"},{"issue":"9","key":"3616_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","volume":"153","author":"PE Stang","year":"2010","unstructured":"Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, et al. Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership. Ann Intern Med. 2010;153(9):600\u20136.","journal-title":"Ann Intern Med"},{"issue":"12","key":"3616_CR30","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2105\/AJPH.2014.302163","volume":"104","author":"B Han","year":"2014","unstructured":"Han B, Compton WM, Gfroerer J, McKeon R. Mental health treatment patterns among adults with recent suicide attempts in the United States. Am J Public Health. 2014;104(12):2359\u201368 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25322299.","journal-title":"Am J Public Health"},{"issue":"10","key":"3616_CR31","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","volume":"162","author":"A Cipriani","year":"2005","unstructured":"Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162(10):1805\u201319.","journal-title":"Am J Psychiatry"},{"key":"3616_CR32","volume-title":"SPRAVATO\u2122 (esketamine) nasal spray, CIII. Prescribing information","author":"Janssen Pharmaceutical Companies","year":"2020","unstructured":"Janssen Pharmaceutical Companies. SPRAVATO\u2122 (esketamine) nasal spray, CIII. Prescribing information. 2020. [cited 2020 Sep 14]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211243lbl.pdf."},{"key":"3616_CR33","volume-title":"Janssen announces U.S. FDA approval of SPRAVATO\u00ae (esketamine) CIII nasal spray to treat depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior","author":"Cision PR Newswire","year":"2020","unstructured":"Cision PR Newswire. Janssen announces U.S. FDA approval of SPRAVATO\u00ae (esketamine) CIII nasal spray to treat depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. 2020. [cited 2020 Sep 14]. Available from: https:\/\/www.prnewswire.com\/news-releases\/janssen-announces-us-fda-approval-of-spravato-esketamine-ciii-nasal-spray-to-treat-depressive-symptoms-in-adults-with-major-depressive-disorder-with-acute-suicidal-ideation-or-behavior-301104437.html."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03616-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03616-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T04:04:29Z","timestamp":1638763469000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03616-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3616"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03616-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"14 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of the Optum claims databases was reviewed by the New England Institutional Review Board (IRB) and was determined to be exempt from broad IRB approval, as this research project did not involve human subjects research. All data were de-identified and HIPAA compliant, and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DMK is an employee of Janssen Research & Development and owns stock in Johnson & Johnson. MSC and FW were employees of Janssen Research & Development when this study was conducted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"608"}}